Coverart for item
The Resource Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002 : [United States], Joel Weissman, (electronic resource)

Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002 : [United States], Joel Weissman, (electronic resource)

Label
Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002 : [United States]
Title
Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002
Title remainder
[United States]
Statement of responsibility
Joel Weissman
Contributor
Subject
Genre
Language
eng
Summary
Using patient self-reports, this study addressed three major questions: (1) What sorts of conditions or problems are discussed during physician visits that include a discussion about a Direct to Consumer (DTC) Advertising drug? (2) What actions are taken by physicians, including additional tests and treatments, as a result of these visits? and, (3) Do outcomes of care differ according to whether the patient takes the DTCA drug that was discussed during the visit or some other drug? Survey questions focused on five main topics: health status and utilization, experience with DTC advertising, visits to doctor to discuss information, outcomes, and health insurance. Respondents were asked to describe their overall health, the estimated time since their last doctor visit, whether they currently took any prescription medications, and from what sources and how often they received medical information. Respondents were also questioned on whether they were familiar with prescription drug advertisements, in what media they had seen such advertisements, whether friends had ever mentioned such advertisements to them, whether those advertisements had provided useful information, and whether such advertisements had ever prompted them to speak to a doctor about taking a prescription drug. Respondents were also queried on the primary ailment about which they had spoken to their doctor, whether their doctor had ever prescribed a drug or drugs to treat that ailment, whether that drug was the same drug they had seen in advertisements, and whether they had filled and taken that prescription. Additional questions were asked of the respondents regarding the results of taking the prescribed drug, satisfaction with the drug's performance, whether they experienced any side effects from the drug, and whether the drug affected their ability to work. Those surveyed were also asked whether they had... Cf.: http://dx.doi.org/10.3886/ICPSR03687
Member of
Additional physical form
Also available as downloadable files.
Cataloging source
ICPSR
Characteristic
combination
Funding information
The AMA-Industry Roundtable Steering Committee, andselected members of the Ad Hoc Working Group on the Economics of thePharmaceutical Industry (AstraZeneca, Aventis, Bristol-Myers Squibb,Johnson & Johnson, Merck, Pharmacia, Pfizer, Wyeth, and the NationalPharmaceutical Council)
Geographic coverage
United States.
Government publication
unknown if item is government publication
http://library.link/vocab/relatedWorkOrContributorName
Inter-university Consortium for Political and Social Research
Series statement
ICPSR
Series volume
3687
http://library.link/vocab/subjectName
  • Advertising
  • Consumer behavior
  • Economic behavior
  • Health behavior
  • Health insurance
  • Health services utilization
  • Media influence
  • Medical care
  • Medical evaluation
  • Medical procedures
  • Medications
  • Physician patient relationship
  • Prescription drugs
  • Public health
Target audience
specialized
Label
Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002 : [United States], Joel Weissman, (electronic resource)
Instantiates
Publication
Note
Title from ICPSR DDI metadata of 2004-10-30
Antecedent source
unknown
Color
mixed
Contents
Part 1: Data File
Control code
MIU01000000000000005047891
Dimensions
unknown
Edition
ICPSR version.
File format
multiple file formats
Governing access note
AVAILABLE. This study is freely available to ICPSR member institutions
Level of compression
unknown
Note
MU: Records downloaded from ICPSR site on Dec. 8, 2009.
Quality assurance targets
unknown
Reformatting quality
unknown
Specific material designation
remote
System control number
  • (MiAaI)ICPSR03687
  • (OCoLC)ocm61155368
  • (MiAaI)ICPSR03687
  • (OCoLC)ocm61155368
System details
Mode of access: Internet
Type of computer file
1 data file + SAS data definition statements + SPSS data definition statements.
Label
Public Health Impact of Direct-to-Consumer Advertising of Prescription Drugs, July 2001-January 2002 : [United States], Joel Weissman, (electronic resource)
Publication
Note
Title from ICPSR DDI metadata of 2004-10-30
Antecedent source
unknown
Color
mixed
Contents
Part 1: Data File
Control code
MIU01000000000000005047891
Dimensions
unknown
Edition
ICPSR version.
File format
multiple file formats
Governing access note
AVAILABLE. This study is freely available to ICPSR member institutions
Level of compression
unknown
Note
MU: Records downloaded from ICPSR site on Dec. 8, 2009.
Quality assurance targets
unknown
Reformatting quality
unknown
Specific material designation
remote
System control number
  • (MiAaI)ICPSR03687
  • (OCoLC)ocm61155368
  • (MiAaI)ICPSR03687
  • (OCoLC)ocm61155368
System details
Mode of access: Internet
Type of computer file
1 data file + SAS data definition statements + SPSS data definition statements.

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
Processing Feedback ...